Skip to content
  • Ayesha Abed Library
  • Language
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
Advanced
  • A review on cyclin-dependent k...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to BibTeX
  • Permanent link
A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliographic Details
Main Author: Sorno, Rubina Haque
Other Authors: Khair, Nishat Zareen
Format: Thesis
Language:English
Published: Brac University 2024
Subjects:
Cyclin dependent kinase 7
CDK- activating kinase
CDK7 inhibitors
Cell cycle
Cancer
Cyclin-dependent kinases
Cellular immunity
Tumors
Microbial cell cycle
Online Access:http://hdl.handle.net/10361/23842
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/10361/23842

Similar Items

  • Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
    by: Flora, Sanzida Alam
    Published: (2024)
  • A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
    by: Khan, Muidul Hasan
    Published: (2024)
  • In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
    by: Ruhee, Noshin Nawer
    Published: (2022)
  • Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
    by: Raju, Md. Ismail
    Published: (2022)
  • A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
    by: Ratu, Tabassum
    Published: (2024)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels

Need Help?

  • Search Tips
  • FAQs